Denali Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Denali Therapeutics by Jpmorgan Chase & Co
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $3.9M | 183k | 21.46 |
2023-09-30 | $3.5M | 168k | 20.63 |
2023-06-30 | $4.7M | 158k | 29.51 |
2023-03-31 | $1.4M | 1.1k | 1302.35 |
2022-12-31 | $5.1M | 184k | 27.82 |
2022-06-30 | $2.9M | 100k | 29.43 |
2022-03-31 | $3.1M | 97k | 32.21 |
2021-12-31 | $3.7M | 83k | 44.59 |
2021-03-31 | $4.3M | 75k | 57.09 |
2020-12-31 | $28M | 331k | 83.75 |
2020-09-30 | $11M | 309k | 36.30 |
2020-06-30 | $5.9M | 245k | 24.18 |
2020-03-31 | $3.1M | 176k | 17.51 |
2019-12-31 | $1.4M | 78k | 17.43 |
2019-09-30 | $241k | 16k | 15.33 |
2019-06-30 | $271k | 13k | 20.58 |
2019-03-31 | $257k | 11k | 23.22 |
2018-12-31 | $240k | 12k | 20.62 |
2018-09-30 | $229k | 11k | 21.70 |
2018-06-30 | $52k | 3.4k | 15.14 |
2018-03-31 | $64k | 3.3k | 19.69 |